Trends in Benzodiazepine Prescribing for US Adolescents and Young Adults From 2008 to 2019
Authors:
Open Access
- 20 December 2021
- journal article
- letter
- Published by American Medical Association (AMA) in JAMA Pediatrics
- Vol. 176 (3) , 312-313
Abstract
Benzodiazepines are commonly prescribed to pediatric patients despite a narrow range of approved indications.1 Like opioids, benzodiazepines are subject to prescription drug misuse and have been associated with increased risk of opioid overdose and opioid-related mortality in adolescents and young adults.2-4 Because limited information is available on the use of benzodiazepines in these age groups, we examined trends in benzodiazepine prescriptions dispensed during a 12-year period, including potential treatment indications and concurrent use with opioids.Keywords
This publication has 6 references indexed in Scilit:
- Polysubstance Involvement in Opioid Overdose Deaths in Adolescents and Young Adults, 1999-2018JAMA Pediatrics, 2021
- Trends in Utilization of Prescribed Controlled Substances in US Commercially Insured Adults, 2004-2019JAMA Internal Medicine, 2020
- Association of Opioid Prescribing Patterns With Prescription Opioid Overdose in Adolescents and Young AdultsJAMA Pediatrics, 2020
- Prescription Benzodiazepine Use in Privately Insured U.S. Children and AdolescentsAmerican Journal of Preventive Medicine, 2019
- Not just heroin: Extensive polysubstance use among US high school seniors who currently use heroinDrug and Alcohol Dependence, 2018
- Vital Signs: Changes in Opioid Prescribing in the United States, 2006–2015MMWR. Morbidity and Mortality Weekly Report, 2017